Tumor Necrosis Factor (TNF) blocking agents are associated with lower risk for Alzheimer's disease in patients with rheumatoid arthritis and psoriasis. [electronic resource]
Producer: 20200720Description: e0229819 p. digitalISSN:- 1932-6203
- Adalimumab -- therapeutic use
- Adolescent
- Adult
- Aged
- Alzheimer Disease -- epidemiology
- Antirheumatic Agents -- therapeutic use
- Arthritis, Psoriatic -- drug therapy
- Arthritis, Rheumatoid -- drug therapy
- Case-Control Studies
- Colitis, Ulcerative -- drug therapy
- Etanercept -- therapeutic use
- Female
- Humans
- Infliximab -- therapeutic use
- Male
- Methotrexate -- therapeutic use
- Middle Aged
- Retrospective Studies
- Risk
- Tumor Necrosis Factor Inhibitors -- therapeutic use
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.